These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25463086)

  • 41. Contributors to newly developed coronary artery disease in patients with a previous history of percutaneous coronary intervention beyond the early phase of restenosis.
    Endo A; Yoshida Y; Kageshima K; Sato H; Suga T; Nasu H; Takahashi N; Tanabe K
    Intern Med; 2014; 53(8):819-28. PubMed ID: 24739601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction.
    Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J
    Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Low-density lipoprotein cholesterol target goal attainment rate and related factors in patients with acute coronary syndrome after percutaneous coronary intervention].
    Zhang B; Dong X; Zhang Y; Huang R; Yin D; Zheng Z; Liu Y; Zhu H; Zhou X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):290-4. PubMed ID: 24924454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
    Prasad A; Rihal CS; Lennon RJ; Singh M; Jaffe AS; Holmes DR
    Circ Cardiovasc Interv; 2008 Aug; 1(1):10-9. PubMed ID: 20031650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
    Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
    Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.
    Nageh T; Sherwood RA; Harris BM; Thomas MR
    Heart; 2005 Sep; 91(9):1181-5. PubMed ID: 16103554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-HDL-cholesterol in an adolescent diabetes population.
    Kuryan RE; Jacobson MS; Frank GR
    J Clin Lipidol; 2014; 8(2):194-8. PubMed ID: 24636179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
    Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
    Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary risk and dyslipidemia in type 2 diabetic patients.
    Udawat H; Goyal RK; Maheshwari S
    J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
    Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
    J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
    Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
    Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.